BMS-536924, an ATP-competitive IGF-1R/IR inhibitor, decreases viability and migration of temozolomide-resistant glioma cells in vitro and suppresses tumor growth in vivo
Qiao ZhouSchool of Public Affairs, University of Science and Technology of China, Hefei, Anhui, People’s Republic of ChinaAbstract: Glioma is the most common type of primary brain tumor. Despite the combination of surgery, chemotherapy, and radiotherapy, the median survival durat...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/bms-536924-an-atp-competitive-igf-1rir-inhibitor-decreases-viability-a-peer-reviewed-article-OTT |